Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Antithrombotics in LM and Bifurcation PCI
Author(s): Charalampos Varlamos , Ioannis Lianos , Despoina-Rafailia Benetou , et al Added: 2 years ago

Intervention
Author(s): Donald E Cutlip Added: 3 years ago
Abstract Coronary artery disease in patients with diabetes is frequently a diffuse process with multivessel involvement and is associated with increased risk for myocardial infarction and death. The role of percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) in patients with diabetes and multivessel disease who require revascularization has been debated and… View more

Prevention & Chronic Conditions
Job title: Interventional Cardiologist
DrGasparini is an Interventional Cardiologist atHumanitas Research Hospital, Italy. He is specialized in treatment of complex coronary artery disease, such as chronic total occlusions, saphenous vein grafts, bifurcations, left main disease and in management of complications.He is CTO operator, proctor and educator. He is the Founder and Course Director of the CTO Live Aid event. Dr… View more
Duk-Woo Park
Job title: Professor of Medicine
Prof Duk-Woo Park is Professor in the Cardiovascular Medicine Division at Asan Medical Center, Seoul, Korea, and an Instructor in Medicine at the University of Ulsan College of Medicine.Prof Park has a particular interest in revascularization strategy (PCI vs. CABG for multivessel and left main disease), antiplatelet/antithrombotic strategey, transcatheter valve interventions (TAVR), major… View more
Left Main Percutaneous Coronary Revascularization
Author(s): Abdulrahman Almoghairi , Nayef Al-Asiri , Khalid Al Johani , et al Added: 9 months ago

Imaging & Diagnostics

Intervention
OPTIMUM Registry: PCI in Patients at Prohibitive Risk for CABG
Author(s): David Kandzari Added: 2 years ago
In this short video, Dr David E Kandzari (Piedmont Heart Institute, Atlanta, GA, US) discusses the easy outcomes from the OPTIMUM registry. The registry is a minimal risk observational study that uses a prospective cohort design to follow patients who have multivessel or left main coronary artery disease (CAD) and are deemed ineligible for coronary artery bypass surgery. The findings, presented… View more

Intervention
AHA 22 Late-Breaking Science Highlights With Dr Joseph Hill
Author(s): Joseph A Hill Added: 1 year ago
AHA 2022 — In this succinct video summary, Dr Joseph A Hill (University of Texas Southwestern Medical Center, Dallas, TX, US) Editor-in-Chief of Circulation shares his perspective on the highlights of AHA Scientific Sessions 2022. What are the most impactful studies of AHA22? 00:00:43: CRISPR 01:41:08: IRONMAN 02:05:00: OCEAN(a)-DOSE 02:46:10: EMPA-KIDNEY 03:55:08: ISCHEMIA-EXTENDed Access our… View more

Heart Failure

Prevention & Chronic Conditions
SUGAR: Amphilimus-eluting Stents VS Zotarolimus-eluting Stents in Patients With DB
Author(s): Rafael Romaguera Added: 2 years ago
In this short interview, Dr Rafael Romaguera (University of Barcelona, SP) discusses the findings from the SUGAR trial.This randomized head-to-head trial aimed to compare Cre8 EVO stents to a contemporary drug-eluting stent (DES) in patients with diabetes (DM) and coronary artery disease. The trial, first presented at TCT 2021, demonstrated that Cre8 EVO stents were non-inferior to Resolute Onyx… View more

Prevention & Chronic Conditions
Role of Intravascular Ultrasound in Guiding Complex Percutaneous Coronary Interventions
Author(s): Brandon Quintana , Akram Ibrahim Added: 3 years ago
Percutaneous coronary intervention (PCI) has been rapidly evolving since its initial application in 1977. Over the years, it has become a mainstay of the treatment of coronary artery disease, including acute coronary syndromes and stable ischemic heart disease. With the advent of novel ancillary technologies, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), it has… View more

Imaging & Diagnostics